Bal Pharma Ltd.
| BSE: 524824 | Sector: Health care |
| NSE: BALPHARMA | ISIN Code: INE083D01012 |
| BSE 00:00 | 20 May | 102.90 |
1.20 (1.18%) |
OPEN
101.85 |
HIGH
105.00 |
LOW
101.80 |
| NSE 00:00 | 20 May | 104.05 |
2.80 (2.77%) |
OPEN
102.00 |
HIGH
105.00 |
LOW
102.00 |
| OPEN | 101.85 |
| PREVIOUS CLOSE | 101.70 |
| VOLUME | 3612 |
| 52-Week high | 148.50 |
| 52-Week low | 88.00 |
| P/E | 15.73 |
| Mkt Cap.(Rs cr) | 160 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bal Pharma Ltd. (BALPHARMA) - Nine Monthly Result
Particulars ( cr) |
Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 |
| Net Sales/Income From Operations | 206.61 | 179.02 | 136.90 | 166.87 | 151.92 |
| Other Income | 2.55 | 1.52 | 1.99 | 1.89 | 1.89 |
| Total Income | 209.15 | 180.54 | 138.89 | 168.76 | 153.81 |
| Total Expenditure | 186.89 | 159.66 | 131.44 | 153.23 | 136.69 |
| Operating Profit | 22.26 | 20.88 | 7.45 | 15.53 | 17.12 |
| Interest | 7.95 | 8.84 | 9.41 | 9.06 | 6.59 |
| Gross Profit | 14.31 | 12.05 | -1.96 | 6.48 | 10.53 |
| Depreciation | 5.12 | 4.93 | 4.00 | 3.75 | 4.77 |
| PBT | 9.19 | 7.12 | -5.95 | 2.73 | 5.77 |
| Tax | 3.39 | 2.40 | -0.57 | -0.25 | 1.30 |
| Net Profit/(Loss) | 5.80 | 4.72 | -5.38 | 2.98 | 4.47 |
| Minority Interest After NP | - | - | - | - | - |
| Net Profit after Minority Interest | - | - | - | - | - |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit After Exceptional Items | 5.80 | 4.72 | -5.38 | 2.98 | 4.47 |
| Equity Share Capital | 14.82 | 14.17 | 14.17 | 14.17 | 14.17 |
| Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS | |||||
| Basic EPS | 3.91 | 3.33 | -3.80 | 2.10 | 3.15 |
| Public Share Holding | |||||
| No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Promoters and Promoter Group Shareholding | |||||
| a) Pledged/Encumbered | |||||
| - Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| - Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| - Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| b) Non-encumbered | |||||
| - Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| - Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. | ||||
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
